Amae Health, a startup focused on severe mental illness, has raised $25 million in Series B funding, the company announced on Thursday.
The San Francisco-based company treats patients battling a range of conditions, including schizophrenia, major depressive disorder, bipolar disorder and borderline personality disorder. It works with health systems — including NewYork-Presbyterian, Cedars-Sinai and Stanford Health Care — to provide outpatient care that combines in-person psychiatric treatment with wraparound support. Patients receive care from a team that includes psychiatrists, therapists, primary care physicians, dietitians, health coaches, peer mentors and clinical care coordinators.
“People living with severe mental illness are among the most underserved and stigmatized in our healthcare system,” said Stas Sokolin, CEO of the company, in an email. “They are often excluded from research and lack access to coordinated, high-quality care that addresses both medical and social needs. Many health systems, stretched by competing priorities, struggle to provide the integrated, whole-person support this population requires. Amae Health was founded to change that.”
Transforming Clinical Content with Ambient & Generative AI
Sheila Bond, MD, talked about the latest trends regarding integration of AI in healthcare.
Amae Health’s Series B round was led by Altos Ventures and included participation from Quiet Capital, Bling Capital, Cedars-Sinai Ventures, Healthier Capital and 8VC. In total, the company has raised more than $50 million.
With the financing, Amae will open more clinics across the country. It currently has clinics in California, North Carolina and New York. It will also leverage the funding to expand partnerships with academic medical centers, as well as support research on schizophrenia, bipolar disorder and treatment-resistant depression.
In addition, the financing will help advance its AI-driven platform. Its platform already offers a dashboard that unifies patient data, monitors health changes and identifies symptom patterns to help providers deliver more personalized care.
Amae’s model has also achieved results. For example, it reduced 30-day hospital readmissions to about 4%, versus the 23% national average, according to the announcement. It also achieved score improvements of 76% for mania, 61% for psychosis and 49% for suicidality through measurement-based care.
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
“Amae is advancing a model of care that prioritizes clinical excellence and compassionate, patient-centered services,” said Dr. Itai Danovitch, chair of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center, in a statement. “By combining an outstanding team of clinicians with a thoughtful approach to long-term care, Amae is delivering outcomes that are both significant and sustainable.”
Ultimately, Amae Health aims to “create a world where someone living with severe mental illness can receive care that is both meaningful and on the cutting edge of what is possible,” Sokolin said.
Other companies that treat severe mental health include Vanna Health and firsthand.
Photo: SIphotography, Getty Images